Research ArticleClinical Investigations
Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [177Lu-DOTA0,Tyr3]Octreotate
Esther I. van Vliet, Eric P. Krenning, Jaap J. Teunissen, Hendrik Bergsma, Boen L. Kam and Dik J. Kwekkeboom
Journal of Nuclear Medicine October 2013, 54 (10) 1689-1696; DOI: https://doi.org/10.2967/jnumed.112.117408
Esther I. van Vliet
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Eric P. Krenning
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Jaap J. Teunissen
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Hendrik Bergsma
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Boen L. Kam
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Dik J. Kwekkeboom
Department of Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 10
October 1, 2013
Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [177Lu-DOTA0,Tyr3]Octreotate
Esther I. van Vliet, Eric P. Krenning, Jaap J. Teunissen, Hendrik Bergsma, Boen L. Kam, Dik J. Kwekkeboom
Journal of Nuclear Medicine Oct 2013, 54 (10) 1689-1696; DOI: 10.2967/jnumed.112.117408
Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [177Lu-DOTA0,Tyr3]Octreotate
Esther I. van Vliet, Eric P. Krenning, Jaap J. Teunissen, Hendrik Bergsma, Boen L. Kam, Dik J. Kwekkeboom
Journal of Nuclear Medicine Oct 2013, 54 (10) 1689-1696; DOI: 10.2967/jnumed.112.117408